COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,694 Articles (22,913 medRxiv, 8,781 bioRxiv)

Most recent first Previous |  Page 342: Articles 3411-3420  | Next

SARS-CoV-2 Orphan Gene ORF10 Contributes to More Severe COVID-19 Disease
Haltom, J. A., Trovao, N. S., Guarnieri, J., Vincent, P., Singh, U., Tsoy, S., O'Leary, C. A., Bram, Y., Widjaja, G. A., Cen, Z., Meller, R., Baylin, S. B., Moss, W. N., Nikolau, B. J., Enguita, F. J., Wallace, D. C., Beheshti, A., Schwartz, R., Wurtele, E. S.
10.1101/2023.11.27.23298847 — Posted: 2023-11-29
Tracking the impact of government response to COVID-19 epidemic: Evidence from India
Mishra, K.
10.1101/2023.11.27.23299097 — Posted: 2023-11-29
Unveiling Vulnerabilities in Maternal-Child Health amidst COVID-19: A Cross-Sectional Study on Food Insecurity and Socio-Demographic Disparities in the U.S.
Henkes, Z., Romo-Palafox, M.
10.1101/2023.11.28.23299080 — Posted: 2023-11-29
Functional and antigenic characterization of SARS-CoV-2 spike fusion peptide by deep mutational scanning
Lei, R., Qing, E., Odle, A., Yuan, M., Tan, T. J. C., So, N., Ouyang, W. O., Wilson, I. A., Gallagher, T., Perlman, S., Wu, N. C., Wong, L. Y. R.
10.1101/2023.11.28.569051 — Posted: 2023-11-29
copepodTCR: Identification of Antigen-Specific T Cell Receptors with combinatorial peptide pooling
Kovaleva, V. A., Pattinson, D. J., Barton, C., Chapin, S. R., Minerva, A. A., Richards, K. A., Sant, A. J., Thomas, P. G., Pogorelyy, M. V., Meyer, H. V.
10.1101/2023.11.28.569052 — Posted: 2023-11-29
Mechanism-based classification of SARS-CoV-2 Variants by Molecular Dynamics Resembles Phylogenetic Tree
Arns, T., Fouquier dHerouel, A., May, P., Tkatchenko, A., Skupin, A.
10.1101/2023.11.28.568639 — Posted: 2023-11-29
Expression and fusogenic activity of SARS CoV-2 Spike protein displayed in the HSV-1 Virion.
Desai, P. J.
10.1101/2023.11.28.568860 — Posted: 2023-11-28
Psychological impact of COVID-19 on frontline healthcare workers during the early months of the pandemic and responses to reduce the burden, helping to prepare for Disease X: A systematic Review
Ludski, J.
10.1101/2023.11.28.23299078 — Posted: 2023-11-28
Social determinants of adult COVID-19 vaccine acceptance and uptake in a Brazilian urban informal community: a longitudinal time-to-event study
Dorion, M., Ticona, J. P. A., Fofana, M. O., Lind, M. L., Nery, N., Victoriano, R., Do Aragao Filho, A. S., Reis, M. G., Costa, F., Ko, A. I.
10.1101/2023.11.28.23298927 — Posted: 2023-11-28
Severe acute myositis and myocarditis upon initiation of six-weekly Pembrolizumab post-COVID-19 mRNA vaccination
Watson, R. A., Ye, W., Taylor, C. A., Cooper, R. A., Tong, O., James, T., Shine, B., Hofer, M., Jenkins, D., Pell, R., Ieremia, E., Jones, S., Maldonado-Perez, D., Roberts, I., Coupe, N., Middleton, M. R., Payne, M. J., Fairfax, B. P.
10.1101/2023.11.24.23296021 — Posted: 2023-11-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).